Spectrum Pharmaceuticals, Inc.(NASDAQ : SPPI)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.61%||68.93||1.0%||$495.04m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.44%||612.44||2.7%||$396.93m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.11%||228.32||1.9%||$341.31m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.15%||2.54||0.7%||$177.56m|
|EXAS||EXACT Sciences Corp.||-6.09%||69.52||17.9%||$158.38m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.60%||89.94||13.7%||$130.59m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-4.52%||130.24||8.2%||$119.35m|
|BMRN||BioMarin Pharmaceutical, Inc.||-3.41%||81.77||4.2%||$99.67m|
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.